Literature DB >> 16192623

Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?

Gianluigi Ferretti, Emilio Bria, Diana Giannarelli, Paolo Carlini, Alessandra Felici, Mario Mandala, Paolo Papaldo, Cecilia Nistico, Alessandra Fabi, Federica Cuppone, Alain Gelibter, Edmondo Terzoli, Francesco Cognetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16192623     DOI： 10.1200/JCO.2005.01.7897

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Thromboembolism in gastrointestinal cancers.

Authors:  Eric D Tetzlaff; Jonathan D Cheng; Jaffer A Ajani
Journal:  Gastrointest Cancer Res       Date:  2008-11

Review 2.  Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.

Authors:  Lara A Kahale; Maram B Hakoum; Ibrahim G Tsolakian; Charbel F Matar; Irene Terrenato; Francesca Sperati; Maddalena Barba; Victor Ed Yosuico; Holger Schünemann; Elie A Akl
Journal:  Cochrane Database Syst Rev       Date:  2018-06-19

Review 3.  Parenteral anticoagulation in ambulatory patients with cancer.

Authors:  Elie A Akl; Lara A Kahale; Maram B Hakoum; Charbel F Matar; Francesca Sperati; Maddalena Barba; Victor E D Yosuico; Irene Terrenato; Anneliese Synnot; Holger Schünemann
Journal:  Cochrane Database Syst Rev       Date:  2017-09-11

4.  Oral anticoagulation is preferable to injected, but only if it is safe and effective: An interview study of patient and carer experience of oral and injected anticoagulant therapy for cancer-associated thrombosis in the select-d trial.

Authors:  Ann Hutchinson; Sophie Rees; Annie Young; Anthony Maraveyas; Kathryn Date; Miriam J Johnson
Journal:  Palliat Med       Date:  2018-11-29       Impact factor: 4.762
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.